ESOMEPRAZOLE MAGNESIUM
ESOMEPRAZOLE MAGNESIUM is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ESOMEPRAZOLE MAGNESIUM; Generic name: ESOMEPRAZOLE MAGNESIUM; Manufacturer: Cipla USA Inc..
| Brand name | ESOMEPRAZOLE MAGNESIUM |
|---|---|
| Generic name | ESOMEPRAZOLE MAGNESIUM |
| Manufacturer | Cipla USA Inc. |
| Used for | 1 INDICATIONS AND USAGE Esomeprazole magnesium for delayed release oral suspension is a proton pump inhibitor (PPI). Esomeprazole magnesium for delayed release oral suspension is indicated for the: Short-term treatment in the healing of erosive esophagitis (EE) in adults and pediatric patients 1 year to 17 years of age and of EE due to acid-mediated GERD in pediatric patients 1 month to less than 1 year of age. ( 1.1 ) Maintenance of healing of EE in adults. ( 1.2 ) Short-term treatment of heartburn and other symptoms associated GERD in adults and pediatric patients 1 year to 17 years of age. ( 1.3 ) Risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in a |
| Dosage | 2 DOSAGE AND ADMINISTRATION 1 A maximum dosage of 20 mg once daily is recommended for patients with severe liver impairment (Child-Pugh Class C). 2 Controlled studies do not extend beyond 6 months. 3 Refer to the amoxicillin and clarithromycin prescribing information for dosage adjustments in elderly and renally-impaired patients. 4 A starting dosage of 20 mg twice daily is recommended for patients with severe liver impairment (Child-Pugh Class C). Population Recommended Adult (2.1) and Pediatri |
| Active ingredient(s) | ESOMEPRAZOLE MAGNESIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=180490d1-c165-4bb9-96b1-12e727256e4e |